文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

碳离子放疗治疗局限性前列腺癌患者的排尿功能与前列腺体积变化分析:一项前瞻性研究

Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study.
PubMed 文献 · Radiat Oncol · 2024-11-19

本前瞻性研究纳入304例组织学确诊的前列腺腺癌患者,接受碳离子放疗总剂量57.6 Gy(RBE),分16次、4周完成。排尿功能参数在治疗结束后立即显著恶化,但3个月后恢复至治疗前水平并稳定至5年;前列腺体积在单纯碳离子放疗患者中降至基线的80%,在联合短期或长期ADT患者中降至基线的60%-70%。

要点

  • 碳离子放疗后排尿功能参数立即显著恶化,3个月恢复至治疗前水平并稳定5年。
  • 平均尿流率在治疗3年后较治疗前显著改善。
  • 前列腺体积在单纯碳离子放疗后降至基线80%,联合ADT后降至60%-70%。

核心结论

  • 碳离子放疗后前列腺癌患者排尿参数立即显著恶化,但3个月后恢复至治疗前水平并稳定5年。

研究设计与样本

  • 前瞻性研究,纳入304例组织学确诊的前列腺腺癌患者,接受碳离子放疗总剂量57.6 Gy(RBE),分16次、4周完成。
  • 在碳离子放疗前、开始治疗后1个月、治疗后3个月以及治疗后1年起每年随访至5年时进行尿流率测定和残余尿测定。
  • 使用经直肠超声测量前列腺体积。

主要发现

  • 尿流率测定参数在治疗结束后立即显著恶化,但3个月后恢复至治疗前水平并稳定至治疗后5年。
  • 平均尿流率在治疗3年后较治疗前显著改善。
  • 前列腺体积在单纯碳离子放疗患者中降至基线的80%,在联合碳离子放疗与短期或长期ADT患者中降至基线的60%-70%。
  • 逻辑二项分析确定排尿后残余尿量(PVR)是预测急性期不良事件的显著因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The potential of carbon ion radiation therapy (CIRT) as a curative treatment for localized prostate cancer (PCa) has garnered attention due to its characteristic dose distribution. We prospectively collected and analyzed over five years to investigate the outcomes of localized PCa treated with CIRT at our institution. PATIENTS AND METHODS: The study included patients with histologically confirmed prostate adenocarcinoma. CIRT treatment was administered at a total dose of 57.6 Gy (RBE) in 16 fractions over four weeks. Uroflowmetry (UFM) and residual urine measurements were performed at various time points: before CIRT treatment, one month after starting CIRT, three months after treatment, and annually for five years starting from 1 year after the completion of CIRT. Prostate volume was measured using transrectal ultrasonography (TRUS). RESULTS: A total of 304 prostate cancer patients were analyzed. UFM parameters were significantly worsened immediately after the treatment. However, they recovered to pretreatment levels after three months and remained stable until five years post-treatment. Notably, Average flow rate showed significant improvement after three years of treatment compared to before the treatment. Prostate volume decreased to 80% of baseline in patients treated with CIRT alone and to 60-70% of baseline in those receiving combined CIRT and either short- or long-term ADT. The logistic-binomial analysis identified post-voiding residual urine volume (PVR) as a significant factor for predicting adverse events in the acute phase. CONCLUSIONS: Following CIRT treatment, the voiding parameters in PCa patients significantly deteriorated immediately. However, after three months, they returned to their pre-treatment levels and remained stable for five years.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Miyazawa Y, Nakayama H, Kawamura H, et al. Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study. Radiat Oncol. 2024. PMID: 39563371. doi:10.1186/s13014-024-02563-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。